Skip to main content
. 2014 Jun 30;2014(6):CD009266. doi: 10.1002/14651858.CD009266.pub2
#1 Prostatic Neoplasms/  
#2 (prostat* adj3 (cancer* or tumo* or neoplas* or carcinom* or malign*)).tw. 
#3 1 or 2 
#4 castration/ or orchiectomy/ 
#5 (orchiectom* or (surg* adj3 castrat*)).tw. 
#6 4 or 5 
#7 exp Androgen Antagonists/ 
#8 (androgen* adj3 antagonist*).mp. 
#9 (nilutamid* or nilandron* or anandron* or RU 23908*).mp. 
#10 (bicalutamid* or Casodex* or Casudex* or ICI 176334*).mp. 
#11 (flutamid* or fluta* or niftolid* or chimax* or cytamid* or eulexin* or drogenil* or euflex* or fluken* or flulem* or flumid* or flutexin* or fugerel* or grisetin* or oncosal* or prostacur* or prostica* or SCH13521* or SCH 13521* or prostogenat* or restotard* or apimid*).mp. 
#12 Flutamide/ 
#13 7 or 8 or 9 or 10 or 11 or 12 
#14 exp Gonadotropin‐Releasing Hormone/ 
#15 (LHRH agonist* or LH RH agonist*).tw. 
#16 luteinizing hormone releasing hormone*.mp. 
#17 Gonadotropin Releasing Hormone*.mp. 
#18 (gnrh agonist* or gn rh agonist*).mp. 
#19 gonadorelin*.mp. 
#20 (leuprolid* or leuprorelin* or enanton* or lupron* or eligard* or TAP 144* or TAP144* or A 43818* or A43818*).mp. 
#21 (goserelin* or ICI118630* or ICI 118630* or zoladex*).mp. 
#22 (buserelin* or receptal* or bigonist* or tiloryth* or profact* or suprecur* or suprefact* or HOE766* or HOE 766*).mp. 
#23 (triptorelin* or Wy42462* or Wy 42462* or decapeptyl* or trelstar* or trimestral* or AY25650* or AY 25650* or CL118532* or CL 118532*).mp. 
#24 buserelin/ or goserelin/ or triptorelin pamoate/
#25 Leuprolide/ 
#26 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 
#27 randomized controlled trial.pt. 
#28 controlled clinical trial.pt. 
#29 random*.ab. 
#30 clinical trials as topic.sh. 
#31 trial.ti. 
#32 27 or 28 or 29 or 30 or 31 
#33 exp animals/ not humans.sh. 
#34 32 not 33 
#35 6 or 26 
#36 13 and 35 
#37 3 and 36 
#38 34 and 37 
#39 remove duplicates from 38 
#40 39 not retracted publication.pt.